All Stories

  1. Loss of Human Epidermal Receptor 2 Expression in Formalin-Fixed Paraffin-Embedded Breast Cancer Samples and the Rescuing Effect of Enhanced Antigen Retrieval and Signal Amplification
  2. An orientation-free ring feature descriptor with stain-variability normalization for pathology image matching
  3. Author Correction: The landscape of viral associations in human cancers
  4. Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes
  5. Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
  6. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  7. Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
  8. Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
  9. Author Correction: Pan-cancer analysis of whole genomes
  10. Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
  11. Author Correction: Genomic basis for RNA alterations in cancer
  12. Author Correction: Patterns of somatic structural variation in human cancer genomes
  13. Author Correction: The evolutionary history of 2,658 cancers
  14. Author Correction: The repertoire of mutational signatures in human cancer
  15. Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer
  16. Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
  17. Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower
  18. Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours
  19. Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer
  20. Author Correction: Inferring structural variant cancer cell fraction
  21. Author Correction: Integrative pathway enrichment analysis of multivariate omics data
  22. Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes
  23. Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
  24. Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
  25. Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
  26. Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
  27. Survival in Breast Cancer Patients with Bone Metastasis: A Multicenter Real-World Study on the Prognostic Impact of Intensive Postoperative Bone Scan after Initial Diagnosis of Breast Cancer (CSBrS-023)
  28. Assessment of accuracy in identifying structural variants using third-generation sequencing for breast cancer in the absence of gold standard
  29. AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status
  30. Germline Variants in 32 Cancer-Related Genes among 700 Chinese Breast Cancer Patients by Next-Generation Sequencing: A Clinic-Based, Observational Study
  31. Two-Dose Vaccination Significantly Prolongs the Duration from Symptom Onset to Death: A Retrospective Study Based on 173,894 SARS-CoV-2 Cases in Khyber Pakhtunkhwa, Pakistan
  32. Tunable mechanical and degradation properties of biodegradable Mg-Y-Zn alloys via Zn content regulation
  33. HER2-low-positive features a distinct subtype in estrogen receptor-positive breast cancer associated with endocrine therapy resistance
  34. Expression of DNA Helicase Genes Was Correlated with Homologous Recombination Deficiency in Breast Cancer
  35. BM-Net: CNN-Based MobileNet-V3 and Bilinear Structure for Breast Cancer Detection in Whole Slide Images
  36. Androgen receptor expression associates with distinctive clinicopathological and molecular features in ER-positive and ER-negative breast cancer
  37. Intraparenchymal breast leiomyoma and atypical leiomyoma
  38. Detection of Structural Variations and Fusion Genes in Breast Cancer Samples Using Third-Generation Sequencing
  39. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  40. Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy
  41. The natural history of breast cancer: a chronological analysis of breast cancer progression using data from the SEER database
  42. Triple negative apocrine breast carcinoma has better prognosis despite poor response to neoadjuvant chemotherapy
  43. Modeling effective tumor burden of primary lesion and metastatic lymph node in breast cancer patients from the SEER database
  44. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  45. Detection of structural variations and fusion genes in breast cancer samples using third-generation sequencing
  46. Identification and Functional Characterization of a Novel Nonsense Variant in ARR3 in a Southern Chinese Family With High Myopia
  47. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  48. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  49. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  50. Detection of structural variations and fusion genes in breast cancer samples using third-generation sequencing
  51. Intraparenchymal Breast Leiomyoma and Atypical Leiomyoma
  52. Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores
  53. Prognosis classification of breast cancer with distant lymph node metastasis IIIc or M1 category
  54. Evaluating and Balancing the Risk of Breast Cancer-Specific Death and Other Cause-Specific Death in Elderly Breast Cancer Patients
  55. A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer
  56. Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapy
  57. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China
  58. RECQL5 KIX domain splicing isoforms have distinct functions in transcription repression and DNA damage response
  59. A Machine Learning Approach to Differentiate Two Specific Breast Cancer Subtypes Using Androgen Receptor Pathway Genes
  60. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  61. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  62. Sex differences in oncogenic mutational processes
  63. Highly Recurrent Copy Number Variations in GABRB2 Associated With Schizophrenia and Premenstrual Dysphoric Disorder
  64. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  65. Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  66. Detecting viruses in tumour tissue to discover links between cancer and infection
  67. Inferring structural variant cancer cell fraction
  68. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
  69. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
  70. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
  71. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
  72. Combined burden and functional impact tests for cancer driver discovery using DriverPower
  73. Divergent mutational processes distinguish hypoxic and normoxic tumours
  74. Genomic footprints of activated telomere maintenance mechanisms in cancer
  75. High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
  76. Integrative pathway enrichment analysis of multivariate omics data
  77. Pathway and network analysis of more than 2500 whole cancer genomes
  78. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
  79. Comprehensive molecular characterization of mitochondrial genomes in human cancers
  80. Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
  81. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
  82. Butler enables rapid cloud-based analysis of thousands of human genomes
  83. Genomic basis for RNA alterations in cancer
  84. Patterns of somatic structural variation in human cancer genomes
  85. The repertoire of mutational signatures in human cancer
  86. Pan-cancer analysis of whole genomes
  87. The evolutionary history of 2,658 cancers
  88. Genomic subtyping of liver cancers with prognostic application
  89. Natural History of Breast Cancer: Reanalyze Nodal Stage and Oestrogen Receptor Status Affecting the Progression of Breast Cancer from SEER Database
  90. Transcriptional regulation of Bcl-2 gene by the PR/SET domain family member PRDM10
  91. Characteristics and Prognostic Factors of Patients With Osteosarcoma Older Than 60 Years From the SEER Database
  92. AluScanCNV2: An R package for copy number variation calling and cancer risk prediction with next-generation sequencing data
  93. Forward and reverse mutations in stages of cancer development
  94. Forward-reverse mutation cycles between stages of cancer development
  95. Coevolution Theory of the Genetic Code at Age Forty: Pathway to Translation and Synthetic Life
  96. Tripartite genome of all species
  97. Feature co-localization landscape of the human genome
  98. GABRB2 Haplotype Association with Heroin Dependence in Chinese Population
  99. Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response
  100. The genetic equidistance result: misreading by the molecular clock and neutral theory and reinterpretation nearly half of a century later